drugset / Trial / NCT01081964
Safety and Efficacy Study of Oral Zabofloxacin in Community Acquired Pneumonia
RandomizedParallel-groupTriple-blindTreatment
Summary
A double-blind, three-arm study, to evaluate the safety and efficacy of two dosing regimens of zabofloxacin (a fluoroquinolone antibiotic) in community acquired pneumonia.
Timeline
- Start
- 2010-03
- Primary completion
- 2012-04
- Completion
- 2012-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Levofloxacin | Small molecule | 500 mg | Oral |
| Subject | Zabofloxacin | Small molecule | 400 mg | Oral |
Indications
No indication recorded.